Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Priority review
Nov 25, 2019
FDA approves novel treatment to target abnormality in sickle cell disease
Nov 21, 2019
FDA takes second action under international collaboration, approves new treatment option for patients with chronic lymphocytic leukemia
Nov 20, 2019
FDA approves first treatment for inherited rare disease
Nov 15, 2019
FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease
Nov 14, 2019
FDA approves new antibacterial drug to treat complicated urinary tract infections as part of ongoing efforts to address antimicrobial resistance
Oct 21, 2019
FDA approves new breakthrough therapy for cystic fibrosis
Oct 08, 2019
FDA awards two grants for natural history studies in rare diseases
Oct 08, 2019
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
Oct 08, 2019
Vast Therapeutics Receives Qualified Infectious Disease Product Status for BIOC11
Sep 27, 2019
FDA approves first treatment for children with rare diseases that cause inflammation of small blood vessels
Sep 17, 2019
FDA takes first action under new international collaboration with Australia and Canada designed to provide a framework for concurrent review of cancer therapies, approving treatment for patients with endometrial carcinoma
Aug 16, 2019
FDA approves treatment for patients with rare bone marrow disorder
Aug 15, 2019
FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor
Aug 13, 2019
Windtree Announces FDA Fast Track Designation for Istaroxime
Aug 05, 2019
Provention Bio Announces Breakthrough Therapy Designation for Teplizumab (PRV-031) for the Prevention or Delay of Clinical Type 1 Diabetes in At-Risk Individuals
Aug 02, 2019
FDA approves first therapy for rare joint tumor
Jun 21, 2019
FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older
Jun 04, 2019
BioMarin Announces Approval of Vimizim® (elosulfase alfa) in China for Treatment of Morquio A Syndrome
May 24, 2019
FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality
May 06, 2019
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
‹‹
Page 2
››
Latest News
Apr 26, 2024
Leeward Renewable Energy Releases Inaugural Sustainability Highlights Report
Apr 26, 2024
Parsec’s Double Award Win Showcases Dedication to Customers and Manufacturing Expertise
Apr 25, 2024
FCA Packaging Invests in Greentree Packaging and Lumber
Apr 25, 2024
TriMas Packaging Receives Silver Award as Strategic Supplier
Apr 25, 2024
Effigis Geo-Solutions Inc. and Provincial Pole Specialists, Inc. Are Rebranded to Osmose Utilities Services...
Apr 25, 2024
Materion Corporation to Announce First Quarter 2024 Financial Results on May 1
Apr 25, 2024
Universal Robots announces seamless integration with Siemens PLCs
Apr 25, 2024
DC Load Simulates AI Microprocessors Power Draw Below 0.8VDC
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events